Neuroinfectious Diseases in Pregnancy

 

 Buy Article Permissions and Reprints

ABSTRACT

Pregnancy is associated with impaired T-cell-mediated immunity putting the woman at risk for infectious diseases not typically seen in immunocompetent individuals. When maternal infection is severe, and when a primary herpesvirus infection is acquired during pregnancy, there is a risk of fetal loss, maternal death, neonatal death, or congenital abnormalities from intrauterine infection. In this review, the authors emphasize specific neurologic infectious diseases that occur in pregnancy, the safety of the antimicrobial therapy of these diseases during pregnancy, as well as the congenital and neonatal sequelae of infection.

REFERENCES

• 1 Medawar P B. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates.  Symp Soc Exp Biol. 1953;  7 320-338
  Google Scholar
• 2 Koch C A, Platt J L. T cell recognition and immunity in the fetus and mother.  Cell Immunol. 2007;  248 (1) 12-17
  Google Scholar
• 3 Silver H M. Listeriosis during pregnancy.  Obstet Gynecol Surv. 1998;  53 (12) 737-740
  Google Scholar
• 4 Landrum L M, Hawkins A, Goodman J R. Pneumococcal meningitis during pregnancy: a case report and review of literature.  Infect Dis Obstet Gynecol. 2009 63624
  Google Scholar
• 5 Temple M E, Nahata M C. Treatment of listeriosis.  Ann Pharmacother. 2000;  34 (5) 656-661
  Google Scholar
• 6 Southwick F S, Purich D L. Intracellular pathogenesis of listeriosis.  N Engl J Med. 1996;  334 (12) 770-776
  Google Scholar
• 7 Janakiraman V. Listeriosis in pregnancy: diagnosis, treatment, and prevention.  Rev Obstet Gynecol. 2008;  1 (4) 179-185
  Google Scholar
• 8 Mylonakis E, Paliou M, Hohmann E L, Calderwood S B, Wing E J. Listeriosis during pregnancy: a case series and review of 222 cases.  Medicine (Baltimore). 2002;  81 (4) 260-269
  Google Scholar
• 9 Jackson K A, Iwamoto M, Swerdlow D. Pregnancy-associated listeriosis.  Epidemiol Infect. 2010;  138 (10) 1503-1509
  Google Scholar
• 10 Bartt R. Listeria and atypical presentations of Listeria in the central nervous system.  Semin Neurol. 2000;  20 (3) 361-373
  Google Scholar
• 11 Uldry P A, Kuntzer T, Bogousslavsky J et al.. Early symptoms and outcome of Listeria monocytogenes rhombencephalitis: 14 adult cases.  J Neurol. 1993;  240 (4) 235-242
  Google Scholar
• 12 van de Beek D, de Gans J, Tunkel A R, Wijdicks E F. Community-acquired bacterial meningitis in adults.  N Engl J Med. 2006;  354 (1) 44-53
  Google Scholar
• 13 Lucas A O. Pneumococcal meningitis in pregnancy and the puerperium.  BMJ. 1964;  1 (5375) 92-95
  Google Scholar
• 14 Tunkel A R, Hartman B J, Kaplan S L et al.. Practice guidelines for the management of bacterial meningitis.  Clin Infect Dis. 2004;  39 (9) 1267-1284
  Google Scholar
• 15 Brouwer M C, Heckenberg S G, de Gans J, Spanjaard L, Reitsma J B, van de Beek D. Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis.  Neurology. 2010;  75 (17) 1533-1539
  Google Scholar
• 16 Crowley P A. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994.  Am J Obstet Gynecol. 1995;  173 (1) 322-335
  Google Scholar
• 17 MacArthur B A, Howie R N, Dezoete J A, Elkins J. School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone.  Pediatrics. 1982;  70 (1) 99-105
  Google Scholar
• 18 Dessens A B, Haas H S, Koppe J G. Twenty-year follow-up of antenatal corticosteroid treatment.  Pediatrics. 2000;  105 (6) E77
  Google Scholar
• 19 Costa M L, Souza J P, Oliveira Neto A F, Pinto E Silva J L. Cryptococcal meningitis in HIV negative pregnant women: case report and review of literature.  Rev Inst Med Trop Sao Paulo. 2009;  51 (5) 289-294
  Google Scholar
• 20 Pebody R G, Andrews N, Brown D et al.. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe.  Sex Transm Infect. 2004;  80 (3) 185-191
  Google Scholar
• 21 Anzivino E, Fioriti D, Mischitelli M et al.. Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention.  Virol J. 2009;  6 40
  Google Scholar
• 22 Young E J, Chafizadeh E, Oliveira V L, Genta R M. Disseminated herpesvirus infection during pregnancy.  Clin Infect Dis. 1996;  22 (1) 51-58
  Google Scholar
• 23 Sauerbrei A, Wutzler P. Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 1: herpes simplex virus infections.  Med Microbiol Immunol (Berl). 2007;  196 (2) 89-94
  Google Scholar
• 24 Hutto C, Arvin A, Jacobs R et al.. Intrauterine herpes simplex virus infections.  J Pediatr. 1987;  110 (1) 97-101
  Google Scholar
• 25 Boucher F D, Yasukawa L L, Bronzan R N, Hensleigh P A, Arvin A M, Prober C G. A prospective evaluation of primary genital herpes simplex virus type 2 infections acquired during pregnancy.  Pediatr Infect Dis J. 1990;  9 (7) 499-504
  Google Scholar
• 26 Whitley R J. Herpes Simplex Viruses. Clinical Virology. Washington, DC: ASM Press; 2004: 375-401
  Google Scholar
• 27 James S H, Kimberlin D W, Whitley R J. Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection.  Antiviral Res. 2009;  83 (3) 207-213
  Google Scholar
• 28 Sheffield J S, Hollier L M, Hill J B, Stuart G S, Wendel G D. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review.  Obstet Gynecol. 2003;  102 (6) 1396-1403
  Google Scholar
• 29 Gardella C, Brown Z A. Managing varicella zoster infection in pregnancy.  Cleve Clin J Med. 2007;  74 (4) 290-296
  Google Scholar
• 30 Sauerbrei A, Wutzler P. Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections.  Med Microbiol Immunol (Berl). 2007;  196 (2) 95-102
  Google Scholar
• 31 Enders G, Miller E. Varicella and herpes zoster in pregnancy and the newborn. In: Arvin A M, Gershon A A, eds. Varicella Zoster Virus: Virology and Clinical Management. Cambridge: Cambridge University Press; 2000: 317-347
  Google Scholar
• 32 Mustafa M B, Arduino P G, Porter S R. Varicella zoster virus: review of its management.  J Oral Pathol Med. 2009;  38 (9) 673-688
  Google Scholar
• 33 Kenneson A, Cannon M J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection.  Rev Med Virol. 2007;  17 (4) 253-276
  Google Scholar
• 34 Cannon M J, Schmid D S, Hyde T B. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection.  Rev Med Virol. 2010;  20 (4) 202-213
  Google Scholar
• 35 Cheeran M C, Lokensgard J R, Schleiss M R. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.  Clin Microbiol Rev. 2009;  22 (1) 99-126
  Google Scholar
• 36 Syggelou A, Iacovidou N, Kloudas S, Christoni Z, Papaevangelou V. Congenital cytomegalovirus infection.  Ann N Y Acad Sci. 2010;  1205 144-147
  Google Scholar
• 37 Torpy J M, Burke A E, Glass R M. JAMA patient page. Cytomegalovirus.  JAMA. 2010;  303 (14) 1440
  Google Scholar
• 38 Pass R F, Zhang C, Evans A et al.. Vaccine prevention of maternal cytomegalovirus infection.  N Engl J Med. 2009;  360 (12) 1191-1199
  Google Scholar
• 39 Boyer K M, Holfels E, Roizen N Toxoplasmosis Study Group et al. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening.  Am J Obstet Gynecol. 2005;  192 (2) 564-571
  Google Scholar
• 40 Jones J, Lopez A, Wilson M. Congenital toxoplasmosis.  Am Fam Physician. 2003;  67 (10) 2131-2138
  Google Scholar
• 41 Montoya J G, Remington J S. Management of Toxoplasma gondii infection during pregnancy.  Clin Infect Dis. 2008;  47 (4) 554-566
  Google Scholar
• 42 Xiao X, Miravalle L, Yuan J et al.. Failure to detect the presence of prions in the uterine and gestational tissues from a gravida with Creutzfeldt-Jakob disease.  Am J Pathol. 2009;  174 (5) 1602-1608
  Google Scholar
• 43 Sperling R, Haak K, Hesson D, Hidde B B. Creutzfeldt-Jakob disease in the obstetric patient.  J Obstet Gynecol Neonatal Nurs. 2005;  34 (5) 546-550
  Google Scholar
• 44 Tabrizi S J, Elliott C L, Weissmann C. Ethical issues in human prion diseases.  Br Med Bull. 2003;  66 305-316
  Google Scholar
• 45 Tyler K L. Emerging viral infections of the central nervous system: part 1.  Arch Neurol. 2009;  66 (8) 939-948
  Google Scholar
• 46 Davis L E, DeBiasi R, Goade D E et al.. West Nile virus neuroinvasive disease.  Ann Neurol. 2006;  60 (3) 286-300
  Google Scholar
• 47 Torno M, Vollmer M, Beck C K. West Nile virus infection presenting as acute flaccid paralysis in an HIV-infected patient: a case report and review of the literature.  Neurology. 2007;  68 (7) E5-E7
  Google Scholar
• 48 Alpert S G, Fergerson J, Noël L P. Intrauterine West Nile virus: ocular and systemic findings.  Am J Ophthalmol. 2003;  136 (4) 733-735
  Google Scholar
• 49 Paisley J E, Hinckley A F, O'Leary D R et al.. West Nile virus infection among pregnant women in a northern Colorado community, 2003 to 2004.  Pediatrics. 2006;  117 (3) 814-820
  Google Scholar
• 50 O'Leary D R, Kuhn S, Kniss K L et al.. Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003–2004.  Pediatrics. 2006;  117 (3) e537-e545
  Google Scholar
• 51 Centers for Disease Control and Prevention (CDC) . Interim guidelines for the evaluation of infants born to mothers infected with West Nile virus during pregnancy.  MMWR Morb Mortal Wkly Rep. 2004;  53 (7) 154-157
  Google Scholar
• 52 Fiore A E, Uyeki T M, Broder K Centers for Disease Control and Prevention (CDC) et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.  MMWR Recomm Rep. 2010;  59 (RR-8) 1-62
  Google Scholar
• 53 Girard M P, Tam J S, Assossou O M, Kieny M P. The 2009 A (H1N1) influenza virus pandemic: a review.  Vaccine. 2010;  28 (31) 4895-4902
  Google Scholar
• 54 Akins P T, Belko J, Uyeki T M, Axelrod Y, Lee K K, Silverthorn J. H1N1 encephalitis with malignant edema and review of neurologic complications from influenza.  Neurocrit Care. 2010;  13 (3) 396-406
  Google Scholar
• 55 Sejvar J J, Uyeki T M. Neurologic complications of 2009 influenza A (H1N1): heightened attention on an ongoing question.  Neurology. 2010;  74 (13) 1020-1021
  Google Scholar
• 56 Fugate J E, Lam E M, Rabinstein A A, Wijdicks E F. Acute hemorrhagic leukoencephalitis and hypoxic brain injury associated with H1N1 influenza.  Arch Neurol. 2010;  67 (6) 756-758
  Google Scholar
• 57 Lapinsky S E. H1N1 novel influenza A in pregnant and immunocompromised patients.  Crit Care Med. 2010;  38 (4, Suppl) e52-e57
  Google Scholar
• 58 ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System . Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study.  BMJ. 2010;  340 c1279
  Google Scholar
• 59 Louie J K, Guevara H, Boston E et al.. Rapid influenza antigen test for diagnosis of pandemic (H1N1) 2009.  Emerg Infect Dis. 2010;  16 (5) 824-826
  Google Scholar

Kelly J BaldwinM.D. 

PGY 3 Resident, Department of Neurology, West Virginia University

P.O. Box 9180, Morgantown, WV 26506

Email: kbaldwin@hsc.wvu.edu